artemether has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, A; Jin, C; Li, Y; Shao, J; Shen, M; Tan, S; Wang, S; Wang, Z; Zhang, F; Zhang, Z; Zheng, S | 1 |
| Chen, A; Jia, Y; Li, M; Shao, J; Wang, F; Wang, L; Zhang, F; Zhang, Z; Zheng, S | 1 |
2 other study(ies) available for artemether and Liver Cirrhosis
| Article | Year |
|---|---|
Iron regulatory protein 2 is required for artemether -mediated anti-hepatic fibrosis through ferroptosis pathway.
Topics: Animals; Artemether; Ferroptosis; Hepatic Stellate Cells; Iron Regulatory Protein 2; Liver Cirrhosis; Mice | 2020 |
P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
Topics: Animals; Apoptosis; Artemether; Carbon Tetrachloride; Cell Death; Cell Proliferation; Disease Models, Animal; Ferroptosis; Hepatic Stellate Cells; Humans; Iron Overload; Lipid Peroxidation; Liver Cirrhosis; Mice; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Protein p53 | 2019 |